A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
Titel:
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
Auteur:
Bhutani, Manisha Foureau, David M. Robinson, Myra Guo, Fei Fesenkova, Kateryna Atrash, Shebli Paul, Barry Varga, Cindy Friend, Reed Pineda-Roman, Mauricio Rigby, Katherine Symanowski, James T. Norek, Sarah Tucker, Mallory R. Druhan, Lawrence J. Voorhees, Peter M. Usmani, Saad Z.